
| ASSET | DATE | % RETURN |
|---|---|---|
SMX (Security Matters) Public Limited Company Class A Ordinary Shares (SMX) | 11/4/2025 - 12/19/2025 | 1,127.52% |
Capricor Therapeutics (CAPR) | 11/4/2025 - 12/19/2025 | 332.89% |
NovaBay Pharmaceuticals (NBY) | 11/4/2025 - 12/19/2025 | 173.15% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 11/4/2025 - 12/19/2025 | 154.63% |
Alumis (ALMS) | 11/4/2025 - 12/19/2025 | 149.1% |
Sigma Lithium Resources (SGML) | 11/4/2025 - 12/19/2025 | 134.07% |
Designer Brands (DBI) | 11/4/2025 - 12/19/2025 | 119.96% |
E W Scripps Co Class A (SSP) | 11/4/2025 - 12/19/2025 | 105.58% |
Forge Global (FRGE) | 11/4/2025 - 12/19/2025 | 96.56% |
Hycroft Mining (HYMC) | 11/4/2025 - 12/19/2025 | 95.92% |
Lyell Immunopharma (LYEL) | 11/4/2025 - 12/19/2025 | 95.65% |
Eventbrite Inc Class A (EB) | 11/4/2025 - 12/19/2025 | 88.51% |
Relmada Therapeutics (RLMD) | 11/4/2025 - 12/19/2025 | 87.78% |
CeriBell (CBLL) | 11/4/2025 - 12/19/2025 | 87.28% |
Ironwood Pharmaceuticals (IRWD) | 11/4/2025 - 12/19/2025 | 80.11% |
TryHard Holdings Limited Ordinary Shares (THH) | 11/4/2025 - 12/19/2025 | 80.02% |
AXT (AXTI) | 11/4/2025 - 12/19/2025 | 78.24% |
Herbalife Nutrition (HLF) | 11/4/2025 - 12/19/2025 | 78.07% |
Abacus Life (ABL) | 11/4/2025 - 12/19/2025 | 77.39% |
Fortrea (FTRE) | 11/4/2025 - 12/19/2025 | 69.66% |
Neuropace (NPCE) | 11/4/2025 - 12/19/2025 | 68.52% |
BioAge Labs (BIOA) | 11/4/2025 - 12/19/2025 | 67.75% |
Natures Sunshine Products (NATR) | 11/4/2025 - 12/19/2025 | 65.37% |
Entrada Therapeutics (TRDA) | 11/4/2025 - 12/19/2025 | 65.06% |
Sight Sciences (SGHT) | 11/4/2025 - 12/19/2025 | 64.87% |